'Betrayal of public trust': Pfizer under fire for resisting Paxlovid compulsory license
By Zoey Becker
The case for testing Pfizer's Paxlovid for treating long COVID
By Julie Steenhuysen
Demand for Pfizer's COVID pills lags around the world
By Michael Erman
Pfizer's Covid Pill Will Soon Be Available Across the U.S.
By Fiona Rutherford & Josh Wingrove